GO:0060627 regulation of vesicle-mediated transport: Cellular Logistics Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060627 regulation of vesicle-mediated transport describes any process that modulates the rate, frequency, or extent of vesicle-mediated transport, the directed movement of substances within vesicles or vesicle membranes into, out of, or within a cell.
• This regulatory term is a biological_process node that sits upstream of core vesicle trafficking machinery and is essential for diverse functions including unconventional protein secretion, extracellular vesicle (EV) biogenesis, and matrix vesicle mineralization.
• Dysregulation of vesicle-mediated transport regulation contributes to cancer progression, drug resistance, and metastasis, as shown in bladder cancer, cervical cancer, and gemcitabine-resistant models.
• Key regulatory genes include those controlling EV cargo sorting, SUMOylation-dependent pathways, and apoptotic vesicle formation, with roles in lymph node metastasis and senolytic responses.
• Single-cell transcriptional profiling has linked vesicle-mediated transport regulation to drug tolerance and combination therapy responses in cancer.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of specific regulatory genes in vesicle-mediated transport pathways.
Description
Vesicle-mediated transport is a fundamental cellular process responsible for the directed movement of proteins, lipids, and other molecules within membrane-bound carriers. The Gene Ontology (GO) term GO:0060627, regulation of vesicle-mediated transport, encompasses any process that modulates the rate, frequency, or extent of this transport. This regulatory node is critical because it controls when, where, and how vesicles form, move, and fuse, thereby influencing processes as diverse as unconventional protein secretion, extracellular vesicle (EV) release, and bone mineralization. Researchers study GO:0060627 to understand how cells adapt their secretory and endocytic trafficking in response to physiological cues and pathological stresses. The regulatory mechanisms can involve post-translational modifications, such as SUMOylation, that promote EV-mediated transmission of long non-coding RNAs and drive lymph node metastasis in bladder cancer. Moreover, vesicle-mediated transport regulation is implicated in drug resistance, as extracellular vesicles can transfer mitochondrial circRNAs to protect against ischemia or modulate gemcitabine sensitivity in bladder cancer. In cancer, single-cell transcriptional changes associated with drug tolerance highlight the importance of vesicle trafficking regulation in therapy response. Given its broad impact, GO:0060627 is a focal point for both basic cell biology and translational research, offering opportunities for therapeutic intervention. This article synthesizes current knowledge on the definition, mechanisms, key genes, disease relevance, and research methods for studying regulation of vesicle-mediated transport.
regulation of vesicle-mediated transport At A Glance
| GO ID | GO:0060627 |
|---|---|
| GO term | regulation of vesicle-mediated transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Modulates the rate, frequency, or extent of vesicle-mediated transport, influencing cargo movement into, out of, and within cells. |
| Related processes | Unconventional protein secretion, extracellular vesicle biogenesis, matrix vesicle mineralization, and apoptotic vesicle formation. |
| Disease relevance | Cancer progression, drug resistance, metastasis, and ischemia-reperfusion injury. |
| Key regulatory mechanisms | SUMOylation, mechanical loading, and transcriptional programs. |
| Research tools | CRISPR knockout, knock-in, overexpression, single-cell RNA-seq, and EV tracking. |
What Is GO:0060627?
According to the QuickGO definition, GO:0060627 regulation of vesicle-mediated transport refers to any process that modulates the rate, frequency, or extent of vesicle-mediated transport, which is the directed movement of substances, either within a vesicle or in the vesicle membrane, into, out of, or within a cell. In simpler terms, it is the cellular control system that decides how fast and how often vesicles carry cargo around the cell and across its boundaries. This regulation can occur at multiple steps, including vesicle formation, cargo selection, vesicle trafficking, tethering, and fusion with target membranes. It is a biological_process term in the Gene Ontology, and it does not have synonyms in the current QuickGO release. The term is distinct from the actual transport process itself; instead, it captures the upstream signals and molecular events that adjust transport activity in response to cellular needs.
Why Is regulation of vesicle-mediated transport Important in Cell Biology?
Regulation of vesicle-mediated transport is important because it governs the spatiotemporal delivery of molecular cargo that cells need to communicate, respond to stress, and maintain homeostasis. Disruption of this regulation is linked to a wide range of diseases, including cancer, where EVs can transfer oncogenic signals and promote drug resistance. For example, SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. In cervical cancer, vesicle-mediated transport-related genes have been used to predict prognosis, immunotherapy response, and drug sensitivity. Moreover, apoptotic vesicle-mediated senolytics require mechanical loading, highlighting the interplay between physical forces and vesicle regulation. Understanding GO:0060627 therefore provides insights into fundamental cell biology and offers potential targets for therapeutic intervention.
• Controls unconventional protein secretion, a pathway for releasing proteins lacking signal peptides.
• Regulates extracellular vesicle biogenesis and cargo sorting, impacting intercellular communication.
• Modulates matrix vesicle-mediated mineralization in bone, affecting osteocytic regulation.
• Influences cancer drug resistance, as shown for gemcitabine in bladder cancer.
• Drives lymph node metastasis through SUMOylation-dependent EV transmission of lncRNA ELNAT1.
• Is required for apoptotic vesicle-mediated senolytic effects under mechanical loading.
• Associates with drug tolerance and combination therapy responses in single-cell cancer studies.
• Protects against cerebral ischemia via EV-mediated delivery of mitochondrial circRNA MTCO2.
• Serves as a prognostic and immunotherapy response biomarker in cervical cancer.
• Provides a rich source of targets for CRISPR-based functional genomics.
What Happens During regulation of vesicle-mediated transport?
Initiation of vesicle formation
In simple terms: The cell decides to make a vesicle and starts assembling its coat.
Regulation of vesicle-mediated transport begins with signals that trigger the assembly of coat proteins and cargo selection at donor membranes. This step determines which molecules will be packaged into vesicles and when. For instance, unconventional protein secretion involves a translocation pathway where specific cargo is directed into vesicles for release. Regulatory inputs such as SUMOylation can modify cargo or machinery to promote vesicle formation, as seen for lncRNA ELNAT1 in bladder cancer cells.
Cargo sorting and vesicle maturation
In simple terms: The vesicle gets loaded with the right cargo and matures.
After initiation, vesicles undergo cargo sorting and maturation, often involving endosomal sorting complexes. This step is regulated by post-translational modifications and adaptor proteins. In extracellular vesicle biogenesis, SUMOylation promotes the selective packaging of lncRNA ELNAT1 into EVs, enhancing lymph node metastasis. Similarly, apoptotic vesicles require mechanical loading to mediate senolytic effects, indicating that physical cues regulate cargo maturation.
Vesicle trafficking and tethering
In simple terms: The vesicle moves to the right place and gets ready to fuse.
Vesicles are transported along cytoskeletal tracks and tethered to target membranes via Rab GTPases and tethering factors. Regulation of this step ensures directional delivery. In matrix vesicle-mediated mineralization, osteocytes regulate the trafficking of vesicles containing calcium and phosphate to the mineralization front. Disruption of trafficking regulation can lead to diseases such as cancer, where EVs carrying oncogenic cargo are misrouted.
Membrane fusion and cargo release
In simple terms: The vesicle fuses with the target membrane and releases its contents.
The final step is fusion with the target membrane, mediated by SNARE proteins and regulated by calcium and other signals. This releases cargo into the extracellular space or into another cellular compartment. For example, extracellular vesicles delivering mitochondrial circRNA MTCO2 fuse with target cells to protect against cerebral ischemia by modulating mPTP-dependent ferroptosis. Regulation of fusion ensures that cargo is delivered only when and where needed.
Feedback and termination
In simple terms: The cell stops or adjusts the transport process.
After cargo release, regulatory feedback mechanisms terminate or modulate the transport process. This can involve degradation of signaling molecules, recycling of membranes, or transcriptional changes. Single-cell transcriptional profiling has revealed that drug-tolerant cancer cells reprogram vesicle-mediated transport regulation, affecting combination therapy responses. Such feedback ensures homeostasis and prevents excessive or inappropriate transport.
Key Genes Involved in GO:0060627 regulation of vesicle-mediated transport
The following genes and proteins are key players in the regulation of vesicle-mediated transport, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ELNAT1 | Long non-coding RNA transmitted via extracellular vesicles; promotes lymph node metastasis | SUMOylation-dependent EV packaging; bladder cancer metastasis model |
| MTCO2 | Mitochondrial circRNA delivered by EVs; modulates mPTP-dependent ferroptosis | Cerebral ischemia protection; EV-mediated delivery |
| H3C14 | Histone H3 variant; extracellular vesicle-mediated regulation contributes to gemcitabine resistance | Bladder cancer drug resistance; EV cargo |
| RAB GTPases | Regulate vesicle trafficking and tethering | General vesicle transport regulation; cancer and mineralization |
| SNAREs | Mediate membrane fusion | Vesicle fusion regulation; unconventional secretion |
| SUMOylation machinery | Post-translational modification promoting EV cargo sorting | Bladder cancer metastasis; ELNAT1 packaging |
| Matrix vesicle proteins | Regulate mineralization via vesicle transport | Bone mineralization; osteocytic regulation |
| Apoptotic vesicle components | Mediate senolytic effects under mechanical loading | Senolytics; mechanical force response |
| Vesicle-mediated transport-related genes (VTRGs) | Predict prognosis and immunotherapy response | Cervical cancer biomarker discovery |
| Drug tolerance-associated genes | Single-cell transcriptional changes linked to vesicle transport | Cancer combination therapy |
| Unconventional secretion cargo | Proteins secreted via vesicle-mediated pathway | Translocation pathway for unconventional protein secretion |
| EV biogenesis regulators | Control extracellular vesicle formation and release | Cancer progression and metastasis |
| Mechanical loading sensors | Link physical forces to apoptotic vesicle regulation | Senolytics and mechanobiology |
| Ferroptosis modulators | Regulate mPTP-dependent ferroptosis via EV cargo | Cerebral ischemia |
| Immunotherapy response genes | Vesicle transport-related genes predict response | Cervical cancer immunotherapy |
| Prognostic gene signatures | Vesicle-mediated transport-related gene sets | Cancer prognosis prediction |
How Is regulation of vesicle-mediated transport Regulated?
Regulation of vesicle-mediated transport is itself controlled by multiple upstream signals. SUMOylation is a key post-translational modification that promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1, thereby driving lymph node metastasis in bladder cancer. Mechanical loading is required for apoptotic vesicle-mediated senolytic effects, linking physical forces to vesicle regulation. Transcriptional programs, as revealed by single-cell RNA sequencing, reprogram vesicle transport during drug tolerance, affecting combination therapy outcomes. Additionally, extracellular vesicles can deliver mitochondrial circRNA MTCO2 to modulate mPTP-dependent ferroptosis, indicating that EV cargo can feedback on cellular stress pathways. These examples illustrate that GO:0060627 is regulated at multiple levels, including post-translational modification, mechanical cues, and transcriptional changes.
regulation of vesicle-mediated transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ELNAT1 | Bladder cancer lymph node metastasis | Knockout of ELNAT1 in bladder cancer cell lines; EV tracking |
| H3C14 | Gemcitabine resistance in bladder cancer | Overexpression or knockout of H3C14; EV isolation |
| MTCO2 | Cerebral ischemia and ferroptosis | EV-mediated delivery in ischemia models; knockout of MTCO2 |
| VTRGs (signature) | Cervical cancer prognosis and immunotherapy | CRISPR library screening; patient-derived xenografts |
| Mechanical loading sensors | Senolytics and aging | Apoptotic vesicle induction under mechanical strain; knockout models |
Cancer progression and metastasis
Dysregulation of vesicle-mediated transport promotes cancer progression and metastasis. In bladder cancer, SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1, which enhances lymph node metastasis. Extracellular vesicle-mediated regulation of H3C14 contributes to gemcitabine resistance in bladder cancer. In cervical cancer, vesicle-mediated transport-related genes have been used to predict prognosis, immunotherapy response, and drug screening. Single-cell transcriptional changes associated with drug tolerance further highlight the role of vesicle trafficking in therapy resistance.
Cerebral ischemia and ferroptosis
Extracellular vesicle-mediated delivery of mitochondrial circRNA MTCO2 protects against cerebral ischemia by modulating mPTP-dependent ferroptosis. This indicates that regulation of vesicle-mediated transport can be harnessed for neuroprotection and that dysregulation may exacerbate ischemic injury.
Bone mineralization disorders
Matrix vesicle-mediated mineralization and osteocytic regulation of bone mineralization are critical for skeletal health. Disruption of vesicle-mediated transport regulation in osteocytes could lead to mineralization defects, although specific disease associations require further study.
Senescence and aging
Apoptotic vesicle-mediated senolytics require mechanical loading, suggesting that regulation of vesicle-mediated transport is involved in clearing senescent cells. This has implications for aging and age-related diseases.
From regulation of vesicle-mediated transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate EV-mediated metastasis? | Knockout of gene X in cancer cells; EV isolation and metastasis assays |
| What is the role of a point mutation in a vesicle transport gene? | Point mutation knock-in using CRISPR in cell lines; functional transport assays |
| How does overexpression of a cargo protein affect vesicle secretion? | Overexpression cell models; live-cell imaging of vesicle trafficking |
| Which genes regulate drug resistance via vesicle transport? | CRISPR library screening; single-cell RNA-seq |
| How does mechanical loading regulate apoptotic vesicles? | Mechanical strain models; knockout of candidate sensors |
| Can EV-delivered circRNA protect against ischemia? | Knock-in of tagged circRNA; EV delivery in ischemia models |
How to Study the regulation of vesicle-mediated transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptional heterogeneity and drug tolerance programs | Cancer combination therapy studies |
| EV isolation and NTA | EV size, concentration, and cargo | LncRNA and circRNA transmission |
| Live-cell imaging | Vesicle dynamics and trafficking | Real-time regulation of transport |
| CRISPR knockout screening | Gene essentiality for vesicle transport | Identifying regulatory genes |
| CRISPR knock-in | Tagged protein localization and function | Tracking vesicle cargo |
| Proteomics | Protein composition of vesicles | Cargo identification |
| Mechanical strain assays | Apoptotic vesicle release under force | Senolytics research |
| Ferroptosis assays | mPTP-dependent cell death | Ischemia protection |
Single-cell RNA sequencing
Single-cell RNA sequencing (scRNA-seq) allows researchers to profile transcriptional changes associated with drug tolerance and vesicle-mediated transport regulation. This method has been used to identify gene expression programs linked to combination therapy responses in cancer. It is particularly useful for uncovering heterogeneity in vesicle transport regulation across cell populations.
Extracellular vesicle isolation and characterization
Extracellular vesicles can be isolated from conditioned media by ultracentrifugation, size-exclusion chromatography, or affinity capture. Characterization includes nanoparticle tracking analysis, electron microscopy, and Western blotting for EV markers. This method is essential for studying EV-mediated transmission of lncRNAs and circRNAs.
Live-cell imaging of vesicle trafficking
Live-cell imaging with fluorescently tagged vesicle markers or cargo proteins enables real-time visualization of vesicle formation, movement, and fusion. This approach can reveal how regulatory signals alter transport dynamics.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression screens can systematically test the role of genes in regulating vesicle-mediated transport. Libraries targeting vesicle transport-related genes have been used to predict prognosis and immunotherapy response in cervical cancer. This method provides causal insights into gene function.
How CRISPR Can Be Used to Study GO:0060627 regulation of vesicle-mediated transport
Knockout
CRISPR knockout is used to delete genes involved in regulation of vesicle-mediated transport to assess loss-of-function phenotypes. For example, knocking out ELNAT1 or its regulatory machinery can reduce EV-mediated lymph node metastasis in bladder cancer models. Knockout of vesicle transport-related genes can also reveal their role in drug resistance and prognosis.
Point Mutation
Point mutation knock-in via CRISPR allows precise modeling of disease-associated variants in vesicle transport genes. This can uncover how specific amino acid changes alter protein function, cargo sorting, or vesicle fusion. Such models are valuable for studying the mechanistic basis of transport regulation.
Knock-in
Knock-in of tagged proteins or reporter genes enables visualization and tracking of vesicle components in live cells. For instance, tagging a cargo protein with a fluorescent marker can reveal its packaging into EVs and delivery to target cells. Knock-in of circRNA MTCO2 could facilitate studies of EV-mediated protection against ischemia.
Overexpression
Overexpression of regulatory genes or cargo proteins can enhance or disrupt vesicle-mediated transport. Overexpressing H3C14, for example, may increase gemcitabine resistance in bladder cancer cells. Overexpression models are useful for gain-of-function studies and for producing large quantities of EVs for therapeutic applications.
How EDITGENE Supports regulation of vesicle-mediated transport Research
Researchers studying regulation of vesicle-mediated transport-related genes often need to determine whether a candidate gene is causally involved in vesicle trafficking, cargo sorting, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and overexpression, along with library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for regulation of vesicle-mediated transport research.
Frequently Asked Questions About regulation of vesicle-mediated transport
What is GO:0060627 regulation of vesicle-mediated transport?
GO:0060627 is a Gene Ontology biological_process term defined as any process that modulates the rate, frequency, or extent of vesicle-mediated transport, the directed movement of substances within vesicles or vesicle membranes into, out of, or within a cell.
What genes are involved in regulation of vesicle-mediated transport?
Key genes include ELNAT1, MTCO2, H3C14, RAB GTPases, SNAREs, and SUMOylation machinery, among others identified in cancer and ischemia studies.
How is vesicle-mediated transport regulated?
It is regulated by post-translational modifications such as SUMOylation, mechanical loading, transcriptional programs, and feedback mechanisms.
What diseases are associated with dysregulation of vesicle-mediated transport?
Dysregulation is linked to cancer progression, drug resistance, metastasis, cerebral ischemia, and bone mineralization disorders.
What methods are used to study regulation of vesicle-mediated transport?
Common methods include single-cell RNA-seq, EV isolation, live-cell imaging, and CRISPR-based functional genomics.
How can CRISPR help study GO:0060627?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of genes involved in vesicle transport regulation.
What is the role of extracellular vesicles in cancer?
Extracellular vesicles can transfer oncogenic lncRNAs and circRNAs, promote metastasis, and contribute to drug resistance.
Can vesicle-mediated transport be targeted therapeutically?
Yes, targeting regulatory pathways such as SUMOylation or EV cargo loading is being explored for cancer and ischemia therapy.
What is the connection between vesicle transport and ferroptosis?
EV-mediated delivery of mitochondrial circRNA MTCO2 modulates mPTP-dependent ferroptosis, protecting against cerebral ischemia.
How does mechanical loading affect vesicle-mediated transport?
Mechanical loading is required for apoptotic vesicle-mediated senolytic effects, linking physical forces to vesicle regulation.
Conclusion
Regulation of vesicle-mediated transport (GO:0060627) is a central biological process that controls the dynamic movement of vesicles and their cargo, impacting diverse physiological and pathological states. From cancer metastasis and drug resistance to cerebral ischemia and bone mineralization, the regulatory mechanisms involving SUMOylation, mechanical cues, and transcriptional programs are critical for cellular homeostasis. Advances in CRISPR-based models and single-cell technologies continue to unravel the complexity of this regulation, offering new opportunities for therapeutic intervention. Understanding GO:0060627 not only illuminates fundamental cell biology but also provides a roadmap for targeting vesicle trafficking in disease.
References
- 1. Zhang M et al.. 2020. A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion.. Cell 181(3):637-652.e15 PMID: 32272059
- 2. Hasegawa T et al.. 2022. Matrix Vesicle-Mediated Mineralization and Osteocytic Regulation of Bone Mineralization.. Int J Mol Sci 23(17) PMID: 36077336
- 3. Huang CS et al.. 2025. Extracellular Vesicle-Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer.. J Extracell Vesicles 14(11):e70179 PMID: 41159684
- 4. Lou S et al.. 2024. Identification of Vesicle-Mediated Transport-Related Genes for Predicting Prognosis, Immunotherapy Response, and Drug Screening in Cervical Cancer.. Immun Inflamm Dis 12(11):e70052 PMID: 39513664
- 5. Chen C et al.. 2021. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.. J Clin Invest 131(8) PMID: 33661764
- 6. Xue Z et al.. 2024. Apoptotic vesicle-mediated senolytics requires mechanical loading.. Theranostics 14(12):4730-4746 PMID: 39239523
- 7. Aissa AF et al.. 2021. Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer.. Nat Commun 12(1):1628 PMID: 33712615
- 8. Yang J et al.. 2025. Extracellular vesicle-mediated delivery of mitochondrial circRNA MTCO2 protects against cerebral ischemia by modulating mPTP-dependent ferroptosis.. Redox Biol 86:103806 PMID: 40768899
